SEVERE HEMORRHAGIC SHOCK DUE TO SPONTANEOUS RUPTURE OF RENAL ANGIOMYOLIPOMA: A CASE REPORT
Main Article Content
Abstract
Introduction: Spontaneous rupture of renal angiomyolipoma (AML) is a rare but life-threatening condition that can lead to severe hemorrhagic shock and acute kidney injury. AML is a benign mesenchymal tumor that is often asymptomatic but carries a risk of rupture, particularly in lesions larger than 4 cm or in patients with underlying conditions such as tuberous sclerosis complex. This case report highlights the intensive management of a patient with ruptured renal AML, emphasizing the importance of early diagnosis, multidisciplinary collaboration, and advanced diagnostic tools.
Case presentation: A 37-year-old male with a history of bilateral AML was admitted due to spontaneous rupture of a large left renal AML, resulting in hemorrhagic shock (hemoglobin 1.9 g/dL), coagulopathy, and acute kidney injury. The patient required emergency intubation, aggressive resuscitation with blood products, and urgent left nephrectomy due to extensive tumor invasion. Postoperatively, the patient developed worsening acute kidney injury requiring continuous renal replacement therapy, along with hemostatic management guided by rotational thromboelastometry (ROTEM). Despite the critical initial condition, the patient stabilized after 72 hours of intensive care, with gradual recovery of renal function and no additional complications.
Conclusion: This case highlights the challenges in managing ruptured AML, particularly in the setting of massive hemorrhage and acute kidney injury. It underscores the crucial role of early diagnosis, timely surgical intervention, and advanced diagnostic tools such as ROTEM in optimizing patient outcomes. A multidisciplinary approach, involving urologists and intensivists, is key to successful management.
Article Details
Keywords
Renal angiomyolipoma, hemorrhagic shock, Wunderlich syndrome, continuous renal replacement therapy, ROTEM.
References
[2] Monich A.G, Bissler J.J, Barreto F.C. Tuberous sclerosis complex and the kidneys: what nephrologists need to know. J Bras Nefrol, 2024, 46 (3): e20240013. doi: 10.1590/2175-8239-jbn-2024-0013en
[3] Simkins A, Maiti A, Cherian S.V. Wunderlich syndrome. The American Journal of Medicine, 2017, 130 (5): e217-e218. doi: 10.1016/j.amjmed.2016.11.031
[4] Sharma S, Ali I, Shetty V. Wunderlich syndrome: a seldom presentation of a relatively ubiquitous tumor. Cureus, 2024, 16 (3): e56126. doi: 10.7759/cureus.56126
[5] Morales J.P et al. Embolization of a bleeding renal angiomyolipoma in pregnancy: case report and review. Cardiovasc Intervent Radiol, 2005, 28 (2): 265-8. doi: 10.1007/s00270-004-1850-2
[6] Nelson C.P, Sanda M.G. Contemporary diagnosis and management of renal angiomyolipoma. J Urol, 2002, 168 (4 Pt 1): 1315-25. doi: 10.1016/s0022-5347(05)64440-0
[7] Kluiving M.W et al. The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with TSC. BMC Nephrology, 2024, 25 (1): 113. doi: 10.1186/s12882-024-03483-4
[8] Gaffoor N et al. Wunderlich syndrome: a rare case associated with bleeding renal angiomyolipoma (AML). Indian J Nephrol, 2024, 34 (3): 271-273. doi: 10.4103/ijn.ijn_397_23
[9] Flum A.S et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol, 2016, 195 (4 Pt 1): 834-46. doi: 10.1016/j.juro.2015.07.126
[10] Bhatt J.R et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs > 4 cm can be offered active surveillance as an initial management strategy. Eur Urol, 2016, 70 (1): 85-90. doi: 10.1016/j.eururo.2016.01.048.